With respect to our present findings, we hypothesize that pharmacological inhibition of uPA‐PAI‐1 heteromerization interferes with pro‐tumorigenic neutrophil responses in breast cancer and consequently attenuates tumor growth and metastasis. The gene discussed is PLAU; the disease is breast carcinoma.